"10.1371_journal.pone.0009041","plos one","2010-02-04T00:00:00Z","Mahamadou A Thera; Ogobara K Doumbo; Drissa Coulibaly; Matthew B Laurens; Abdoulaye K Kone; Ando B Guindo; Karim Traore; Mady Sissoko; Dapa A Diallo; Issa Diarra; Bourema Kouriba; Modibo Daou; Amagana Dolo; Mounirou Baby; Mahamadou S Sissoko; Issaka Sagara; Amadou Niangaly; Idrissa Traore; Ally Olotu; Olivier Godeaux; Amanda Leach; Marie-Claude Dubois; W Ripley Ballou; Joe Cohen; Darby Thompson; Tina Dube; Lorraine Soisson; Carter L Diggs; Shannon L Takala; Kirsten E Lyke; Brent House; David E Lanar; Sheetij Dutta; D Gray Heppner; Christopher V Plowe","Malaria Research and Training Center, University of Bamako, Bamako, Mali; Howard Hughes Medical Institute/Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America; GlaxoSmithKline Biologicals, Rixensart, Belgium; EMMES Corporation, Rockville, Maryland, United States of America; Malaria Vaccine Development Program, U.S. Agency for International Development, Washington, D.C., United States of America; Division of Malaria Vaccine Development, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America","Conceived and designed the experiments: MAT OKD DC AKK ABG KT DAD AD MSS IS AN AO OG AL MCD WRB JC LS CD KEL DGH CVP. Performed the experiments: MAT OKD DC MBL AKK ABG KT MS DAD ID BK MD AD MB MSS IS AN IT KEL BH CVP. Analyzed the data: MAT MBL MSS IS DT TJD SLT KEL BH CVP. Contributed reagents/materials/analysis tools: AO OG AL MCD WRB JC DL SD DGH. Wrote the paper: MAT MBL OG MCD JC LS CD SLT KEL DGH CVP.","SD and DEL hold patents for the FMP2.1 vaccine antigen. OG, AL, WRB, MCD and JC are or were employees of GlaxoSmithKline Biologicals, the manufacturer of the proprietary Adjuvant System AS02A, and hold shares in GlaxoSmithKline. None of the other authors have declared conflict of interest.","2010","02","Mahamadou A Thera","MAT",35,TRUE,22,21,10,11,TRUE,TRUE,FALSE,0,NA,FALSE
